Results 11 to 20 of about 1,816,488 (304)

Antibiotic therapy for bacterial pneumonia

Journal of Pharmaceutical Health Care and Sciences
Pneumonia is a common infection in patients of all ages. Determining its etiology and selecting antibiotic therapy are challenging for physicians in both private practice and hospitals.
Hideo Kato
doaj   +2 more sources

Clinical characteristics and predictive models for hospitalized patients with COVID-19 combined with bacterial pneumonia. [PDF]

PLoS ONE
BackgroundThis study aimed to analyze the clinical characteristics of hospitalized patients with COVID-19 combined with bacterial pneumonia and establish a predictive model to assist clinicians in the differential diagnosis and evaluation of the ...
Man Yuan, Mei Liang, Jian Xu, Da He, Yanfang Zhang, Xiaoran Li, Jinzhi He, Yang Yang, Zhiyong Zong, Junyan Qu   +9 more
doaj   +2 more sources

Bacterial Pneumonia

The Professional Medical Journal, 2019
Objectives: To assess the correlation between laboratory markers (C Reactive Protein, White Blood Cells) and treatment failure with Oral Amoxicillin in Bacterial Pneumonia in children aged 2-59 months old at Pediatrics Emergency Department LUMHS Hyderabad. Study Design: Cross sectional study.
Yasmin Memon, Zubair Memon, Saleem Shaikh, Salma Shaikh, Muhammad Nadeem Chohan   +4 more
semanticscholar   +5 more sources

Comparison between Acute Phase Reactant in COVID-19 Pneumonia And Bacterial pneumonia [PDF]

Al-Azhar International Medical Journal, 2022
Background: Several instances of pneumonia from an unknown cause were recorded in the city of Wuhan, China in December 2019, and were later confirmed as coronavirus illness 2019. (COVID-19).
Abdallah Soliman, Mohamed sedky, Hosam Alfeky   +2 more
doaj   +1 more source

Multi-drug resistant gram-negative bacterial pneumonia: etiology, risk factors, and drug resistance patterns

Pneumonia, 2022
Bacterial pneumonia is one of the most serious public health issues owing to its medical and economic costs, which result in increased morbidity and mortality in people of all ages around the world.
Muluneh Assefa
semanticscholar   +1 more source

Nanoparticle-modified microrobots for in vivo antibiotic delivery to treat acute bacterial pneumonia

Nature Materials, 2022
Bioinspired microrobots capable of actively moving in biological fluids have attracted considerable attention for biomedical applications because of their unique dynamic features that are otherwise difficult to achieve by their static counterparts.
Fangyu Zhang, Jia Zhuang, Zhengxing Li, Hua Gong, Berta Esteban-Fernández de Ávila, Yaou Duan, Qiangzhe Zhang, Jiarong Zhou, Lu Yin, Emil Karshalev, Weiwei Gao, V. Nizet, Ronnie H. Fang, Liangfang Zhang, Joseph Wang   +14 more
semanticscholar   +1 more source

A model for COVID-19 and bacterial pneumonia coinfection with community- and hospital-acquired infections [PDF]

Mathematical Modelling and Numerical Simulation with Applications, 2022
We propose a new epidemic model to study the coinfection dynamics of COVID-19 and bacterial pneumonia, which is the first model in the literature used to describe mathematically the interaction of these two diseases while considering two infection ways ...
Angel G. C. P'erez, D. A. Oluyori
semanticscholar   +1 more source

Prokineticin 2 promotes macrophages-mediated antibacterial host defense against bacterial pneumonia

International Journal of Infectious Diseases, 2022
: Objectives: Bacterial pneumonia is a common serious infectious disease with high morbidity and mortality. Prokineticin 2 (PK2) has recently been identified as a novel immunomodulator in a variety of diseases; however, its role in bacterial pneumonia ...
Qianqian Tu, Xiaoyan Yu, Wei Xie, Yetao Luo, Hong Tang, Kai Chen, Yanting Ruan, Yue Li, Jie Zhou, Yibing Yin, Dapeng Chen, Zhixin Song   +11 more
doaj   +1 more source

Probiotic-based nanoparticles for targeted microbiota modulation and immune restoration in bacterial pneumonia

National Science Review, 2022
While conventional bacterial pneumonia mainly centralizes avoidance of bacterial colonization, it remains unclear how to restore the host immunity for hyperactive immunocompetent primary and immunocompromised secondary bacterial pneumonia.
Jieni Fu, Xiangmei Liu, Z. Cui, Yufeng Zheng, Hui Jiang, Yu Zhang, Zhaoyang Li, Yanqin Liang, Shengli Zhu, P. Chu, K. Yeung, Shuilin Wu   +11 more
semanticscholar   +1 more source

Frequency of Neurological Diseases After COVID-19, Influenza A/B and Bacterial Pneumonia

Frontiers in Neurology, 2022
Introduction COVID-19 might affect the incidence of specific neurological diseases, but it is unknown if this differs from the risk following other infections.
P. Zarifkar, C. Peinkhofer, M. Benros, D. Kondziella   +3 more
semanticscholar   +1 more source